Active Pregnancy, Children & Inherited Conditions Psychology & Behaviour

Genomic Disorders and Cognitive Development

Funder MRC (part of UKRI)
Recipient organisation University of Cambridge
Funding £2.0M
Period Mar 2022 — Mar 2027

In plain English

AI plain-English summary

Around 1 in 100 people worldwide has intellectual disability, and for over half of them, new genetic tests can now pinpoint a specific cause. This matters because, until recently, most people with intellectual disability never learned why they had it. Without a cause, support was reactive—treating problems like seizures or anxiety only after they appeared. With a genetic diagnosis, researchers can start linking specific DNA changes to the cognitive and mental health challenges each person faces. The gap this project fills is the missing connection between a molecular cause and a person’s real-world difficulties. If this research succeeds, it could shift care from symptom management to prediction and prevention. Knowing the genetic basis of a person’s intellectual disability might allow clinicians to anticipate which physical or mental health problems are likely to emerge—and intervene earlier. This could improve quality of life for people with intellectual disability and reduce the need for high-level support. The work is not immediately practical; it is fundamental science that builds the knowledge base needed for future tailored therapies and support strategies.

View original technical description
About 1 in 100 people worldwide has intellectual disability (ID), meaning that they have significant lifelong difficulties with learning, communication and independent living skills. ID often occurs alongside other physical and mental health difficulties, meaning that people with ID require high levels of support and often have poor quality of life. Currently the support that can be provided is mainly reactive and symptom-focused - tackling problems as and when they arise. This is because, until recently, we did not know the cause of ID for the majority of people, so it was not possible to predict problems at an earlier stage and provide more effective support tailored to the cause of each person’s condition. This situation is now changing fast. New genetic testing technologies mean that it is possible to identify a specific cause in more than half of people with ID. Testing is available within the NHS, and in many global health settings. Genetic diagnosis provides new opportunities to understand each person’s ID, and use this knowledge to improve physical and mental health. To achieve this, our research aims to bridge the gaps between the molecular cause of ID and the lifelong cognitive and mental health difficulties experienced by each person.

View the original record at the funder ↗

Researchers

Kate Baker (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Intellectual Disability and Mental Health: Assessing Genomic Impact on Neurodevelopment (IMAGINE)
Intellectual Disability and Mental Health: Assessing Genomic on Impact on Neurodevelopment
The lifelong health & wellbeing of adults with neurodevelopmental disorders associated with intellectual disabilities
Deciphering Developmental Disorders
Genotype and Phenotype in Inherited neurodegenerative diseases

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.